Article
Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings.
Investigative ophthalmology & visual science - 1 Nov 2010
Ufret-Vincenty Rafael L, Aredo Bogale, Liu Xinran, McMahon Anne, Chen Peter W, Sun Hui, Niederkorn Jerry Y, Kedzierski Wojciech
Abstract excerpt
PURPOSE: Complement factor H (Cfh) is a key regulator of the alternative complement pathway. A Cfh variant (Y402H) increases the risk for AMD. The purpose of this study was to develop a pathophysiologically relevant animal model of AMD based on this genetic risk factor. METHODS: The authors generated chimeric Cfh transgenic mouse lines using two constructs consisting of the human CFH sequence for SCR6-8 (with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
